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ABSTRACf 
The cardDoembryonic antiaen (CEA) gene family belongs to the 
immllDCJllobuUn luperfamily and can be subdivided Into the CEA and 
JII1!IPIaDC)'-spedfic glycoprotein subgroups. The basic structure of the 
eac:oded proteiDs consists of,in addition to a leader, one IgV-tike and 2, 
3, or 6 IgC-Uke domains. These domains are followed by varying COOH-
terminal regIoas responsible for secretion, transmembrane anchori .... or 
InsertiOD into the membrane by a g1ycosyl phOlphatidylinositol tail. Here 
we report OD the characterization of CGM6, a new member of the CEA 
gene subgroup, by complementary DNA cloalng. The deduced coding 
region comprises 349 amino acids and consists of a leader, one IgV-like, 
two IgC-Hke do_os, and a hydrophobic region, which Is replaced by a 
g1ycosyl phosphatidyUnosltol moiety in the matore protein. CGM6 tran-
scripts "ere ODly foand thus far in leukocytes of chronic myeloid leukemia 
patients, in nornW bODe marrow, and in marginal amounts in normal 
granulocytes. The CGM6 gene product might, therefore, represent a 
myeloid marker. Analyses of CGM6 prote~xpresslng HeLa transrec-
tants with IIIOIIOClonaI antibodies strongly indicate that the CGM6 gene 
codes for the CEA family member NCA-95. 
INTRODUcnON 
CEAJ is a marker in human tumors of epithelial origin (I). 
Although it lacks absolute tumor specificity, it is widely used 
for the postoperative surveillance of intestinal cancer patients 
(I). Earlier immunological studies identified a number of closely 
related molecules which cross-react with CEA (reviewed in Ref. 
2). Recent findings suggest that CEA and related antigens might 
function as cell adhesion molecules and/or ecto-ATPases (3-
5). The CEA-related proteins are all highly glycosylated and 
show a large degree of variability with respect to their molecular 
sizes and expression patterns. For example, CEA and and two 
glycosylation variants encoded by the closely related NCA gene 
(NCA-SO and NCA-90 or TEX) have been described to be 
present in colon adenocarcinomas and in smaller amounts in 
normal colonic mucosa (6-8), whereas in normal granulocytes, 
NCA-90, NCA-9S, and NCA-160 are expressed (9, 10). The 
CEA-related proteins are encoded by a gene family (reviewed 
in Ref. 11). Analysis of the genes, as far as they are known, 
indicate a basic domain structure for these molecules as well as 
homology to the immunoglobulin supergene family. The pro-
teins consist of a leader peptide, an NH2-terminal or IgV-like 
domain, a varying number of IgC-like domains, and a short 
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COOH-terminal domain, which mayor may not allow mem-
brane anchorage. In the biliary glycoprotein I, another member 
of the CEA family, the IgC-like domains are followed by a 
transmembrane and a cytoplasmic domain (12-14). For CEA 
and the NCA-SO/90, a short hydrophobic COOH-terminal 
region is posttranslationally replaced by a GPI moiety (15-18). 
Recently, a second major subgroup has been identified as be-
longing to the CEA family based on sequence comparisons. 
These molecules represent the heterogenous PSG, for which 
about 10 genes have so far been defined (reviewed in Ref. 19). 
In a previous report from our group on the expression of 
CEA-related genes, tissue-specific expression patterns for the 
CEA and the NCA gene could be determined (20). These studies 
also revealed the existence of a CEA-related, 2.2-kilobase 
mRNA species in CML leukocytes, which was not found in the 
other tissues investigated. This finding indicates that this CEA-
related mRNA or its encoded protein may be of potential use 
either as a tumor or a lineage marker. For this reason, it is 
important to characterize this mRNA more closely. In this 
presentation, we report on the isolation of corresponding cDNA 
clones and detailed analyses regarding structure and expression, 
as well as tentative assignment to the NCA-9S protein. 
MATERIALS AND METHODS 
Moaoclonal Antibodies. The mouse monoclonal antibodies 26/3/13, 
4/3/17,47, 192, and 202 were raised against purified CEA and NI 
against NCA-50 (6,21). Their specificities have been described before 
(6,9, 10,22, 23). 
Cells and TIssues. HeLa cells were cultured at 37'C in Falcon (Becton 
Dickinson, Heidelberg, FRG) dishes containing RPMI 1640 medium 
supplemented with 10% fetal calf serum, penicillin, and streptomycin. 
Human primary tumors or human tumors propagated in nude mice 
(24) were frozen and stored in liquid nitrogen immediately after resec-
tion. Leukocytes from CML patients as well as granuloc:ytes and 
Iymphocytes from healthy adults were isolated from peripheral blood 
or buffy coats, respectively, by centrifugation through a PercoH (phar-
macia, Freiburg, FRG) step gradient acc:ording to the manufacturer's 
protocol and were directly used for RNA isolation. Bone marrow was 
obtained from a healthy donor and used without further fractionation. 
IsolatiOD and CharacterizatiOD of cDNA Clones. Phage DNAs of a >--
gtll cDNA library constructed from the spleen of a CML patient 
(Clontech, Palo Alto, CA) were hybridized on nitrocellulose filters in 
replicas with the 32P_labeled (25) DNA fragment covering the coding 
region of an NCA cDNA clone (26) in 6x SSPE (Ix = 0.18 M NaCI-
10 mM sodium phosphate, pH 7.4-1 mM EDTA)-5x Denhardt's solu-
tion (Ix = 0.02% each of Ficoll (Pharmacia, Freiburg, FRG), bovine 
serum albumin fraction V (Serva, Heidelberg, FRG), polyvinyl pyrrol-
idon), 0.5% SDS, 30% formamide at 42'C overnight. The filters were 
washed in 2x SSPE, 0.1% SDS at 6O"C for I h. The positive clones 
were plaque purified three times (27). The EcoRI cDNA inserts were 
subcloned into M 13 vectors (Boehringer Mannheim, Mannheim, FRG) 
and sequenced according to the method of Sanger et al. (28) with the 
Sequenase sequencing kit (United States Biochemicals: Renner, Dann-
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Stadt, FRG) using universal and I7mer internal oligonucleotide
primers. For comparison of the nucleotide and amino acid sequences
the computer program "Align"4 was used.
RNA Purification and Northern and Southern Blot Hybridizations.
Total RNA was extracted from fresh cells or from tissues pulverized in
liquid nitrogen by the guanidinium thiocyanate method (29) or by the
acid phenol method (30). For Northern blot hybridizations, RNAs were
electrophoresed on 1% agarose gels containing 10 mM methylmercury
hydroxide, transferred to charged nylon membranes (GeneScreen Plus,
Du Pont de Nemours, Dreieich, FRG), and hybridized with "P-labeled
cDNA fragments as described before (20). The cDNA fragments were
labeled either by priming with random hexamers (25) or with the
universal KS primer on a BgH fragment from the Bluescript plasmid
(Stratagene, Heidelberg, FRG) with the subcloned CGM6a cDNA,
which contains the 3'-untranslated region of CGM6 cDNA (Fig. \A).
The blots were washed under low (2x SSPE. 1% SDS, 60Â°C)and high
stringency conditions (O.lx SSPE, 0.1% SDS, 62Â°C)for 45 min,
respectively. Southern blot hybridizations were performed as described
before (20), apart from the final wash, which was at 62Â°C.
Construction of pBEH/CGM6 Expression Plasmid. First, a cDNA
clone with the complete open reading frame of CGM6 was constructed
in the Bluescript vector using the unique Tthl 1II site, present in both
\-CGM6a and X-CGM6b cDNAs (Fig. \A). The resulting full-length
cDNA fragment was excised with the restriction endonucleases Xmal
and Hindlll, which both cut in the flanking polylinker regions, and
cloned into the Xmal/Hindlll sites of the expression vector
pBEHpUC9 (31) downstream of the SV40 early promoter. The identity
of the constructs was confirmed by restriction endonuclease and partial
sequence analysis.
Stable Transfection and Identification of CGM6-expressing lici .a
Cells. Transfection of HeLa cells was performed by the method of
Feigner et al. (32) as described recently (33). For cotransfection. 1 x
IO6 HeLa cells on a 10-mm plastic Petri dish were treated with 1 ug
pSV2neo (34) which confers resistance toward the neomycin-derivative
G418, a 20-fold molar excess (20 ^g) of the CGM6 expression construct
pBEH/CGM6, and 40 ag of Lipofectin (GIBCO-BRL, Karlsruhe,
FRG) in 3 ml RPMI 1640 without serum. Control cultures were
transfected with 1 ^g of pSV2neo DNA alone. Selection for cells
expressing the bacterial neo gene was carried out in the presence of 0.6
mg/ml of the active antibiotic G418 (GIBCO-BRL). After 4 weeks
colonies were isolated using cloning cylinders.
Flow Cytometry Analysis. Flow cytometry (35) of cloned G418-
resistant cells was performed on a FACScan flow cytometer (Becton
Dickinson, Sunnyvale, CA) as described before (33). The optimal
concentrations of the monoclonal antibodies were determined by serial
dilutions.
PI-PLC Treatment. Adherent cells were removed from culture dishes
with phosphate-buffered saline (without Ca2* and M2"1"ions) containing
0.5 mM EDTA and singled by pipeting. Cells (1 x 106)in 200 u\
phosphate-buffered saline, 3% fetal calf serum, 0.1% sodium azide were
incubated with 0.6 unit/ml PI-PLC from Bacillus thuringiensis (Di-
anova, Hamburg, FRG) for 3 h at 37Â°C.Cells were recovered by
centrifugation for 5 min at 400 x g and analyzed by flow cytometry as
described before (33).
RESULTS
Isolation and Analyses of CGM6 cDNA Clones. For the
isolation of cDNA clones, which correspond to the 2.2-kilobase
CEA-related mRNA species found in CML leukocytes (20, 36),
we screened 1 x 106plaques of a X-gt11 cDN A library prepared
from the spleen of a CML patient. As a probe we used the
coding region of the NCA cDNA clone 9 (26). Four positive
clones were identified. Partial sequence analyses revealed that
two of these clones are derived from NCA mRNA, which is
also found in CML leukocytes (20). The inserts of the two
remaining clones were completely sequenced according to the
strategy shown in Fig. \A. Both cDNA fragments overlap and
together cover 32 base pairs of the 5'-noncoding region, a 1047-
base pair open reading frame, and 285 base pairs of the 3'-
untranslated region (Fig. \B). The encoded putative preprotein
consists of 349 amino acids with a relative M, of 38,125 (minus
leader: M, 34,326). Comparison of the deduced amino acid
sequence with that of NCA (26) or PSGs (37) revealed that the
putative CGM6 protein has a similar domain organization,
consisting of a 34-amino acid leader peptide (L), an NH2-
terminal or IgV-like domain of 108 amino acids (N), two IgC-
like domains (type A and B) of 92 and 86 amino acids, respec
tively, with the characteristic pairs of conserved cysteine resi
dues, and a 29-amino acid hydrophobic membrane domain (M)
CGM6 mRNA
ACGM6a
xCGM6b
4OObp
B
' M. Trippe! and R. Friedrich, unpublished data.
Fig. 1. Domain organization 1.11and nucleotide sequence and deduced amino
acid sequence (B) of the CGM6 cDNA. A: boxes, domains of the coding region
of CGM6 mRNA (L, leader; N, NH2-terminal or IgV-like domain; A.B. IgC-like
domain type A and B: M, membrane domain; C, cysteine): thin lines, noncoding
regions. CGM6a and CGM6b cDNAs were sequenced with internal (O) or
universal (â€¢)primers according to the strategy shown by arrows. Dolled line in
CGM6b, an unspliced intron sequence. The Tthl\ li (T) and Bgl\ (B) restriction
endonuclease sites used for construction of the full-length cDNA and preparation
of the hybridization probe, respectively, are shown. The flanking EcoRl (Â£)sites
have been created by the cloning procedure. In B, the nucleotide sequence is
numbered from the start codon. Arrows, domain borders; underline, consensus
sequences for NHj-glycosylation; open arrowhead, end of the membrane domain
exon in the CEA gene; closed arrowhead, point of divergence to the sequence of
NCAcDNA.
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(Fig. 1). Eleven potential sites for NH2-glycosyIation are pres
ent, all of them at conserved positions in comparison with the
NCA-50/90 protein, which has one additional glycosylation
site (26).
The nucleotide sequences of X-CGM6a and X-CGM6b di
verge directly downstream of the A domain (Fig. IA). Compar
ison with intron sequences of the NCA gene5 revealed that the
clone \-CGM6b is obviously derived from an incompletely
spliced mRNA precursor, since it contains an intron sequence
between the exons encoding the A and B domains as found for
other thus far characterized members of the CEA gene family
(11,38,39).
Furthermore, comparison of the nucleotide sequence of the
various domains of CGM6 with the corresponding sequences
of members of the CEA and PSG subgroups clearly indicate
that CGM6 belongs to the CEA subgroup. The highest overall
similarity for the coding region is found with NCA (85% at the
nucleotide and 78% at the amino acid level), which has the
same domain organization as CGM6 (L-N-A-B-M). The se
quence similarity with NCA mRNA, however, stops abruptly
41 nucleotides beyond the CGM6 stop codon. This position
corresponds closely to the site of divergence of the CEA and
NCA mRNA (26). Beyond this position a rather high similarity
(75%) to the corresponding sequence of CEA mRNA is found
(Fig. IB). However, CGM6 mRNA lacks the Alu-type repetitive
element, which is inserted in CEA mRNA 120 nucleotides
downstream of the stop codon (40).
CGM6 mRNA Is Specifically Expressed in CML Leukocytes
and in Bone Marrow. To prove that the CGM6 clones are
derived from the 2.2-kilobase mRNA present in CML leuko
cytes, Northern blot analyses with total RNA from pooled
leukocytes of several CML patients were performed. With a
probe from the coding region of NCA, which hybridizes under
the applied conditions with the mRNAs of all members of the
CEA subgroup, two mRNA species of 2.2 and 2.5 kilobases
could be detected (Fig. 2/4, lane 2). As a probe for CGM6
mRNA a DNA fragment covering the 3'-untranslated region
of X-CGM6a was used. Under stringent conditions, the 2.2-
kilobase mRNA and to a lesser degree a 3.0-kilobase RNA
species were found to hybridize, whereas a probe specific for
NCA mRNA (20) hybridized with the 2.5-kilobase mRNA
species (Fig. 2A, lanes 1 and 3). In leukocytes of four other
individual CML patients, the 2.2- and 3.0-kilobase RNA species
could also be detected in variable amounts with the CGM6
probe under stringent conditions. The Northern blot experi
ment for two of these CML RNAs are shown in Fig. IB (lanes
I and 2). An mRNA species of apparently the same size as the
2.2-kilobase species of CML leukocytes was also identified in
total RNA from normal bone marrow along with three high
molecular weight RNA species, not found in CML leukocytes
(Fig. 2C, lane 2). Due to their large size, the latter RNAs could
represent CGM6 mRNA precursors. None or only marginal
amounts of the 2.2-kilobase mRNA species were found in total
RNA from lymphocytes and granulocytes, respectively, from
healthy donors, although comparable amounts of 0-actin
mRNA were present in these RNA preparations (Fig. 2B). To
further determine the expression pattern of CGM6-related
mRNAs we have analyzed a number of human tumors and
mÃ©tastasesas well as a few normal tissues by Northern blot
hybridization. No CGM6 mRNA could be detected in any of
the following tissues examined: one adenocarcinoma of the
! J. Thompson, unpublished results.
pancreas, one of the lung and two of the breast, two of the
stomach and five of the colon, three serous and four mucinous
carcinomas of the ovary, one squamous carcinoma of the cervix
and of the lung, one small cell and one large cell carcinoma of
the lung, one thyroid gland, one gallbladder and one liver
carcinoma, one kidney hypernephroma, one osteosarcoma and
one pleural mesothelioma, and normal colonie mucosa and
placenta, although in all cases a signal for 0-actin mRNA was
found (data not shown). The lack of a hybridization signal with
RNA from colon tumors as well as from placenta, which contain
CEA and PSG mRNAs, respectively (20, 37), rules out a cross-
hybridization of the CGM6 probe with these mRNAs, which
show in the corresponding regions 75 and 60% [PSG3 mRNA
(41)] similarity, respectively (42). To examine, whether the 2.2-
kilobase, the 3.0-kilobase and the high molecular weight RNA
species are derived from multiple, closely related genes or from
one gene, a Southern blot with EcoRl- or Ssfl-digested human
genomic DNA was hybridized with the same CGM6 probe.
One major and one or two minor hybridizing fragments could
be observed under stringent conditions (Fig. 2D, lanes I and 2).
The faint bands could have been caused by cross-hybridization
with closely related genes or the probe used may contain infor
mation from more than one exon (see below). As expected from
the Northern blot experiments, genomic DNA fragments of
different sizes (fcoRI, 2.7 kilobases; Sstl, 13 kilobases) hybrid
ized with a probe from the related 3'-untranslated region of the
CEA cDNA (Fig. 2D, lanes 3 and â€¢/),which is in good agreement
with those found by restriction mapping of the CEA gene (43).
The CGM6 Gene Probably Encodes NCA-95. We have at
tempted to resolve the question, whether the CGM6 gene
encodes a known but not yet assigned member of the CEA
family (2). For this purpose, we examined G418-resistant HeLa
cell clones, which had been obtained by transfection with a
CGM6 cDNA-containing expression vector together with a
G418 resistance-confering plasmid (pSV2neo) with MAbs of
varying specificity (Table 1). As a control, HeLa cell clones
which were transfected with pSV2neo alone was used. MAb 47,
which recognizes CEA and NCA-95 (9), reacted with a CGM6
HeLa transfectant (HeLa-CGM6/l) but not with the HeLa-
neol (Fig. 3A). On the other hand, MAb 192, which recognizes
an epitope present on CEA, NCA-50/90, and NCA-160 but
apparently not on NCA-95 (9, 10), stained HeLa-CGM6/l
cells only marginally (Fig. 3ÃŸ).NCA-producing HeLa cells
transfected with the plasmid pBHE/NCA (33) were strongly
labeled with MAb 192 which was comparable to the reaction
of Hela-CGM6/l cells with MAb 47 (data not shown). There
fore, the marginal reaction of MAb 192 with the CGM6-
expressing cells is probably due to a weak cross-reaction of the
CGM6-encoded protein not seen in immunoprecipitation ex
periments rather than a generally low affinity of MAb 192 to
CEA-related molecules. This interpretation is substantiated by
the observation that MAb 202, which binds to CEA, NCA-50,
and NCA-95, also strongly reacted with HeLa-CGM6/l cells
(Fig. 3C). A marginal reaction of the HeLa-CGM6/l transfec
tant was also observed with a MAb specific for the two glyco
sylation variants NCA-50 and NCA-90 (MAb Nl) and with
MAb 4/3/17 (Fig. 3, D and E) , which recognizes both CEA
and a M, 160,000 NCA species (33). These reactions are pos
sibly due to the presence of small amounts of CEA-like anti-
gen(s) endogenous to HeLa cells rather than to the expression
of the CGM6 protein because the negative control (HeLa-neol)
was labeled to the same extent by these antibodies (Fig. 3, D
and E). A MAb specific for CEA (MAB 26/3/13) did not react
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Fig. 2. Northern blot analyses of CGM6 transcripts in myeloid and lymphoid cells. Total RNA (10 Mg)from pooled leukocytes of six CML patients (A, lanes I-
3) or leukocytes of individual CML patients (fi, lanes I and 2; C, lane I) and from normal granulocytes (B, lanes 3 and 5), normal lymphocytes (B, lanes 4 and 6), or
bone marrow (C, lane 2) of healthy donors were used. After electrophoretic separation of the RNAs in methylmercury hydroxide-containing agarose gels and transfer
to charged nylon membranes, the RNAs were hybridized with a "P-labeled probe covering the .^'-untranslated region of the CGM6 cDNA (A, lane I; B; and C). After
decay of the probe used before, the blots were rehybridized with probes from the coding [the 500-base pair Pst\ and the 500-base pair Psll/EcoRl fragment of clone 9
(26)] or 3'-untranslated region of NCA cDNA [the 1.45-kilobase Â£coRIfragment of clone 9 (26)], respectively (A, lanes 2 and 3), or a mouse f)-actin probe [(49); B
and C). D, Southern blot analysis of the CGM6 and CEA genes. Human DNA (2.5 fig) digested with Â£coRland Si/I, respectively, were size fractionated, blotted, and
hybridized with the probe from the 3'-untranslated region of the CGM6 cDNA (lanes I and 2). Subsequently, after stripping, this membrane was rehybridized with a
408-base pair Rsal/Psll fragment from the 3'-untranslated region of a CEA cDNA clone [(20); lanes 3 and 4). All blots were washed under stringent conditions (O.lx
SSPE, 62Â°C)except after hybridization with the probe from the coding region of the NCA cDNA or the /i-actin probe (2x SSPE, 60Â°C).
Table I Reactivity ofanli-CEA/NCA MAbs with purified antigens
The reactivity of the MAbs has been assessed by immunoprecipitation of the
radioactively labeled CEA-related antigens (6. 9, 10, 22, 23). All MAbs were of
the IgG 1 isotype.
CEA NCA-50/90 NCA-95 NCA- 160
MAb NI
MAb 47
MAb 4/3/17
MAb 26/3/13
MAb 192
MAb 202 NDÂ°
" ND, not determined.
with the CGM6 transfectant. (Fig. 3F).
The CGM6-encoded Protein Is Anchored to the Membrane by
a GPI Moiety. In both CEA and NCA preproteins the hydro-
phobic membrane domain is replaced by a GPI anchor during
maturation (15-18,33). To investigate whether the homologous
hydrophobic domain of the CGM6 protein is also substituted
by a GPI tail and anchored to the membrane in the same
fashion, we have treated the CGM6 transfectant HeLa-CGM6/
1 with bacterial PI-PLC, which specifically catalyzes the hy
drolysis of the phosphate ester between the phosphatidyl and
inositol moiety of the GPI anchor. Subsequent reaction with
MAB 47 and flow cytometry revealed that most of the MAB
47 target was removed from the cells by PI-PLC treatment
(Fig. 4).
DISCUSSION
In this paper we have described a new member of the CEA
gene family, named CGM6. Altogether, six genes belonging to
the CEA subgroup have been identified by analyses of genomic
or cDNA clones: CEA, NCA, BGP, CGM1, COM2, and CGM6
(19). The genes for CEA, NCA, and biliary glycoprotein 1 have
been assigned to known members of the CEA protein family
on the basis of partial amino acid sequences (13, 14, 18, 26,
40), whereas for the CGM1 and CGM2 genes no transcripts or
47 192 202 NI 4/3/17 28/3/13
HeLa-CGM6/l
HeLa-neo)
0123 O 1 2 3 0123 OÃ-as 01934
fluorescence intensity
Fig. 3. Characterization of the CGM6 protein by MAbs. A HeLa cell line stably transfected with the CGM6 expression plasmid and pSV2neo (HeLa-CGM6/1)
or a control cell line transfected with pSV2neo alone (HeLa-neol) were reacted with various MAbs which recognize different CEA-related antigens and stained with
biotinylated goat anti-mouse IgGl and A-phycoerythrin-coupled streptavidin ( ). For a negative control, the first antibody was omitted ( ). The degree of
reaction of the antibodies was assessed by flow cytometric analysis of 10'' cells each. The fluorescence intensity is shown in logio units.
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fluorescence intensity
Fig. 4. Release of the CGM6 protein by PI-PLC-treatment. HeLa-CGM6/l
transfectants, before ( ) and after treatment with Pl-PLC ( ) were
stained with MAb 47 followed by biotinylated goat anti-mouse IgGl and R-
phycoerythrin-coupled streptavidin and analyzed by flow cytometry. As controls,
cells with ( ) or without (â€¢â€¢â€¢)PI-PLC treatment were analyzed omitting
the primary antibody. The fluorescence intensity is shown in logic units.
proteins have been found so far (44).
In an attempt to determine the identity of the protein encoded
by the CGM6 gene that is presumably expressed in CML
leukocytes, it is important to know which CEA-related antigens
are present in these cells. Three such antigens have been char
acterized in CML leukocytes6 and in normal granuloytes (9,
10). In addition to NCA-90, which is presumably identical with
TEX (8) and has been shown by protein sequencing to be derived
from the NCA gene (8), two other, not yet assigned NCA
species of M, 95,000 [formerly called NCA-97 by our group
(6)] and 160,000 have been identified. These three antigens can
be discriminated by a panel of monoclonal antibodies (33). The
reaction pattern of a CGM6-expressing transfectant with MAbs
of different specificity strongly suggests that the CGM6 gene
encodes NCA-95. For a definite assignment of CGM6 to NCA-
95, however, partial amino acid sequences have to be obtained.
NCA-95 has been found in normal granulocytes (10), in CML
leukocytes,6 in colonie tumors, and in normal lung tissue (6).
The presence of NCA-95 in the latter two tissues is probably
due to infiltrating granulocytes (9). This is in agreement with
our results that CGM6-like mRNAs species could only be
detected in CML leukocytes and bone marrow cells but not in
colon adenocarcinomas. Because CGM6 mRNA species could
not be detected in a number of other tissues tested, CGM6
might represent a specific marker for the myeloid lineage,
although more tissues still have to be tested. With polyclonal
anti-NCA antibodies, which cross-react with all three above
mentioned NCA species, myelocytes, metamyelocytes, seg
mented neutrophils, and partially promyelocytes, but not blast
cells, were shown to express NCA(s) (45, 46). Further experi
ments have to be performed to identity the CGM6 mRNA-
containing myeloid precursors. In normal mature granulocytes,
CGM6 mRNA was only barely detectable. This could possibly
be due to very low mRNA levels in these short-lived, terminally
differentiated cells or to synthesis of this NCA species only
occurring in granulocyte precursors, corresponding to the mye
loid cell populations found in the peripheral blood of CML
patients and in normal bone marrow.
' Results to be published elsewhere.
Both CGM6 and NCA mRNA encode proteins with the same
domain arrangement, including a hydrophobic domain, which
is, however, five amino acids longer in CGM6. Despite this
fact, this domain probably also serves as a signal for GPI tailing
as in NCA and CEA (15-18, 33), as shown in this paper.
In the CEA gene this signal peptide, together with 39 nucleo-
tides of the 3'-untranslated region, is encoded by a separate
exon (43). Similarly, the transmembrane domain of BGP, which
represents an extended CEA-like membrane domain, created
by the insertion of a single nucleotide in front of the correspond
ing stop codon, is also encoded by a separate exon (12). Inter
estingly, in CEA, BGP, and NCA mRNA, the sequences diverge
completely beyond the point which corresponds to the end of
the CEA and BGP membrane exons. Therefore, it can be
hypothesized that in the genes for CGM6 and NCA the 3'-
noncoding regions are also disrupted by introns at the same
positions. In analogy, the same exon/intron organization can
be expected to exist for the PSG2, PSG3, and PSG5 genes
whose mRNAs have a CEA gene-related organization in their
COOH-terminal domains and 3'-noncoding regions (37, 47).
The function of the CGM6 gene product (NCA-95) is un
known. Further studies are needed to clarify whether the CGM6
gene encodes a protein with a similar function as the product
of the structurally closely related NCA gene, which has been
shown to convey cell adhesion in transfected cells (4) or other
recently described myeloid cell adhesion molecules (48). Fur
thermore, it will be interesting to know whether NCA-95 and
NCA-90 perform their function on the same cells or on cells of
different myeloid subpopulations.
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ADDENDUM
In parallel to our studies, Arakawa et al. (Biochem. Biophys. Res.
Commun., 166: 1063-1071, 1990) characterized a cDNA clone (NCA-
W272) from a normal WBC library, encoding a new species of NCA,
which is identical to our CGM6 clones.
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